Evidence map›Paper›PMID 27607247›Full record

ArticlePloS one2016

Single-Step Fabrication of Computationally Designed Microneedles by Continuous Liquid Interface Production.

Ashley R Johnson, Cassie L Caudill, John R Tumbleston, Cameron J Bloomquist, Katherine A Moga, Alexander Ermoshkin, David Shirvanyants, Sue J Mecham, J Christopher Luft, Joseph M DeSimone

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. 3D printed microneedles: revamping transdermal drug delivery systems.Drug delivery and translational research · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ashley R JohnsonJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, United States of America.
Cassie L CaudillDepartment of Molecular Pharmaceutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27510, United States of America.
John R TumblestonCarbon, Redwood City, California, United States of America.
Cameron J BloomquistDepartment of Molecular Pharmaceutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27510, United States of America.
Katherine A MogaDepartment of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Alexander ErmoshkinCarbon, Redwood City, California, United States of America.
David ShirvanyantsCarbon, Redwood City, California, United States of America.
Sue J MechamLineberger Comprehensive Cancer Center Institute for Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
J Christopher LuftDepartment of Molecular Pharmaceutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27510, United States of America.
Joseph M DeSimoneJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microneedles, arrays of micron-sized needles that painlessly puncture the skin, enable transdermal delivery of medications that are difficult to deliver using more traditional routes. Many important design parameters, such as microneedle size, shape, spacing, and composition, are known to influence efficacy, but are notoriously difficult to alter due to the complex nature of microfabrication techniques. Herein, we utilize a novel additive manufacturing ("3D printing") technique called Continuous Liquid Interface Production (CLIP) to rapidly prototype sharp microneedles with tuneable geometries (size, shape, aspect ratio, spacing). This technology allows for mold-independent, one-step manufacturing of microneedle arrays of virtually any design in less than 10 minutes per patch. Square pyramidal CLIP microneedles composed of trimethylolpropane triacrylate, polyacrylic acid and photopolymerizable derivatives of polyethylene glycol and polycaprolactone were fabricated to demonstrate the range of materials that can be utilized within this platform for encapsulating and controlling the release of therapeutics. These CLIP microneedles effectively pierced murine skin ex vivo and released the fluorescent drug surrogate rhodamine.

Indexed as

MicroinjectionsAcrylatesAnimalsDrug Delivery SystemsFluorescent DyesMice, NudePermeabilitySkin AbsorptionAcrylatesFluorescent Dyestrimethylolpropane triacrylate

Identifiers

PMID27607247
PMCPMC5015976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.